Beware risk of adverse events associated with GBCAs
Risks associated with gadolinium-based contrast agents (GBCAs) differ by drug, and clinicians would do well to educate themselves about these differences, according to research published October 14 in Expert Opinion on Drug Safety.To make the situation more complicated, not all possible adverse events from GBCAs are noted in drug packaging, wrote a team led by Lu Wang, PhD, of Yantai Yuhuangding Hospital in Yantai, China."Some adverse events [noted] in this study were not mentioned in the package inserts, which need more attention and research to ensure the clinical safety," the group explained.The U.S. Food and Drug Admin...
Source: AuntMinnie.com Headlines - October 17, 2023 Category: Radiology Authors: Kate Madden Yee Tags: Clinical News MRI Source Type: news

Former CEO Pleads Guilty to Causing the Distribution of Adulterated and Misbranded Medical Devices Intended to Treat Migraine Headaches
FDA OCI, Mark Wright, Dolor Technologies, medical device, SphenoCath, migraine, headaches, nerve, block, no FDA clearance, approval, adulterated, misbranded, investigational, studies, sphenopalatine ganglion, SPG, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - October 16, 2023 Category: Medical Law Authors: DOJ Source Type: news

Does physiologic post-concussion disorder cause persistent post-traumatic headache? - McPherson JI, Nazir MSZ, Willer BS, Leddy JJ, Haider MN.
PURPOSE OF REVIEW: One system classifies patients with symptoms after concussion into physiologic, vestibulo-ocular, cervicogenic, and mood/cognition post-concussion disorders (PCD) based upon the preponderance of specific symptoms and physical impairments... (Source: SafetyLit)
Source: SafetyLit - October 16, 2023 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

What the location of your headache REALLY means
London-based GP Dr Ann Nainan says a forehead headache could be caused by eye strain, pain in the temple could be a cluster headache and a tension headache can cause pain at the back of the head. (Source: the Mail online | Health)
Source: the Mail online | Health - October 15, 2023 Category: Consumer Health News Source Type: news

6 Stories Show the Human Toll of Poland ’ s Strict Abortion Laws
This project was supported by the Pulitzer Center [time-brightcove not-tgx=”true”] Krzysztof Sowinski has cried every day since his wife Marta, who was five months pregnant, died of sepsis in 2022; he believes doctors put Marta’s life in danger by not giving them the option to terminate the pregnancy while the fetus’ heart was still beating. Janusz Kucharski also lost his partner Justyna to sepsis in the fifth month of a pregnancy. She left behind two boys. It is likely, reproductive-rights advocates say, that these women would be alive if not for Poland’s increasingly restrictive abort...
Source: TIME: Health - October 13, 2023 Category: Consumer Health News Authors: Anna Pamula Tags: Uncategorized abortion Source Type: news

Late-breaking data for Roche ’s BTK inhibitor fenebrutinib show brain penetration and significant reduction in lesions in patients with relapsing multiple sclerosis
New data from Phase II FENopta study in relapsing multiple sclerosis (RMS) show fenebrutinib crosses the blood-brain barrier with the potential to act directly on the chronic inflammation related to multiple sclerosis (MS)More than 90% relative reduction in new/enlarging T2 lesions and new T1 gadolinium-enhancing (Gd+) lesions with fenebrutinib beginning at 8 weeksThe safety profile of fenebrutinib was consistent with previous and ongoing clinical trials across more than 2,500 people to dateBasel, 13 October 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new data from the Phase II FENopta study showing that inve...
Source: Roche Media News - October 13, 2023 Category: Pharmaceuticals Source Type: news

Late-breaking data for Roche ’s BTK inhibitor fenebrutinib show brain penetration and significant reduction in lesions in patients with relapsing multiple sclerosis
New data from Phase II FENopta study in relapsing multiple sclerosis (RMS) show fenebrutinib crosses the blood-brain barrier with the potential to act directly on the chronic inflammation related to multiple sclerosis (MS)More than 90% relative reduction in new/enlarging T2 lesions and new T1 gadolinium-enhancing (Gd+) lesions with fenebrutinib beginning at 8 weeksThe safety profile of fenebrutinib was consistent with previous and ongoing clinical trials across more than 2,500 people to dateBasel, 13 October 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new data from the Phase II FENopta study showing that inve...
Source: Roche Investor Update - October 13, 2023 Category: Pharmaceuticals Source Type: news

My 81-year-old father took his own life when loophole stopped him getting £117,000 payout for botched dental surgery which left him in years of pain: Daughter slams system as 'not fit for purpose'
Clive Worthington suffered nerve damage in 2008 after a procedure to replace his dentures. His weight plummeted as he was unable to eat properly and was plagued by migraines and insomnia. (Source: the Mail online | Health)
Source: the Mail online | Health - October 13, 2023 Category: Consumer Health News Source Type: news

The effects of migraine and traumatic brain injury on subjective cognitive functioning in veterans in the Million Veteran Program - Ozturk E, Merritt V, Afari N, Gasperi M.
This study examined the relationship between migraine, TBI,... (Source: SafetyLit)
Source: SafetyLit - October 12, 2023 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Online Merchants Are Losing Significant Revenue With This Billing Mistake
With clear, recognizable billing descriptors, merchants can save themselves the headache of avoidable transaction disputes and keep their customers happy and returning. Opinions expressed by Entrepreneur contributors are their own. Do you know that line-item text that shows up on your debit or…#fintech #visa #mastercard #somewhatoften #veryoften #improved #enhanced (Source: Reuters: Health)
Source: Reuters: Health - October 10, 2023 Category: Consumer Health News Source Type: news

Putin faces Ukraine war headache after Israel attack
Russian President Vladimir Putin could stare down renewed Western support for Ukraine in the wake of days of bloodshed in Israel and Gaza, one expert has told Newsweek, as the death toll following the weekend's violence rises. "The recent escalation in the Middle East will only encourage Western…#russian #vladimirputin #western #ukraine #israel #gaza #middleeast #oleksandrkraiev #palestinian #hamas (Source: Reuters: Health)
Source: Reuters: Health - October 9, 2023 Category: Consumer Health News Source Type: news

Another Headache For Disney: Activist Investor Nelson Peltz Is Back And Said To Be Seeking Board Seats
Activist investor Nelson Peltz, who dropped a long battle with Disney early this year, has amassed a large stake in the media giant and is said to be seeking board seats. Peltz” Trian Fund, one of Disney’s largest investors with a stake valued at upward of $2.5 billion, is expected to request…#activist #nelsonpeltz #disney #peltztrianfund #bobiger #bobchapek #trian #mideast #postcovid #espn (Source: Reuters: Health)
Source: Reuters: Health - October 9, 2023 Category: Consumer Health News Source Type: news

How Old Do You Have to Be To Receive Yellow Fever Vaccine?
Discussion In the United States, Yellow Fever (YF) is rare and usually due to traveler’s coming to the US from Africa (34 countries) or South America (13 countries, see maps here) This wasn’t always true. There were numerous outbreaks in the past few centuries. However, after the Spanish-American War, a YF commission was sent to Cuba that proved YF was mosquito-borne and 1 year later major improvement was seen due to a multi-pronged mosquito control program. “In May 1900, the U.S. Army,…formed the U.S. Army Yellow Fever Commission to gather data in Cuba that might inspire improvements in the publi...
Source: PediatricEducation.org - October 9, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Should you pick Novavax ’s COVID-19 shot over mRNA options?
For cardiologist Eric Topol, this week’s vaccine news presented a personal dilemma. Topol, who directs the Scripps Research Translational Institute and is a popular commenter on COVID-19 research, had hoped to get an updated COVID-19 vaccine from Novavax, rather than a messenger RNA (mRNA) shot from Pfizer or Moderna. Novavax relies on an older, protein-based approach that has shown long-lasting effects against other pathogens, and Topol wondered whether it might produce more durable protection. On Tuesday, it seemed he might get his chance: a drugstore he visited for an mRNA vaccine ran out of doses, and hours later the...
Source: ScienceNOW - October 6, 2023 Category: Science Source Type: news